Pricing Log in Create free account

Azitra, Inc. (AZTR) vs Skye Bioscience, Inc. (SKYE)

Azitra, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Azitra, Inc. and Skye Bioscience, Inc. are of similar size ($4.6M and $4.4M). Skye Bioscience, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.3×. Across the 11 metrics below, Azitra, Inc. leads on 7 and Skye Bioscience, Inc. on 4.

Valuation

Metric AZTR SKYE Biotechnology median
P/E 1.27 n/m 10.60
P/S 2.50 16.46 9.40
P/B 0.20 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.47 n/m 0.66
EV/Sales (9.10) 3.61 9.02
Earnings yield 78.60% (1,026.26%) (32.88%)
Free cash flow yield (786.51%) (779.11%) (23.13%)

Profitability

Metric AZTR SKYE Biotechnology median
Gross margin 100.00% 68.04% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (233.87%) (51.96%)
Return on assets (190.69%) (159.80%) (46.06%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR SKYE Biotechnology median
Revenue growth (TTM) 58.18% — 6.76%
EPS growth (last fiscal year) 85.68% (93.15%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR SKYE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 0.95 4.97
Net debt to EBITDA 0.20 0.45 1.01

Dividend

Metric AZTR SKYE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZTR SKYE Biotechnology median
Market cap 4.39m 4.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack